FindTrial
Sign In

To compare effects of propofol and remifentanil on the parameters of postoperative extubation in patients scheduled for radical resection of endometrial carcinoma under general anesthesia

To compare effects of propofol and remifentanil on the parameters of postoperative extubation in patients scheduled for radical resection of endometrial carcinoma under general anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025773
Enrollment
Unknown
Registered
2019-09-07
Start date
2019-11-01
Completion date
Unknown
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial carcinoma

Interventions

control group:Intravenous propofol
observe group:intravenous remifentanil

Sponsors

The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients undergoing endometrial carcinoma radical via general anesthesia, ASA I-II, aged no more than 65 years, BMI: 18 to 22 kg/m2.

Exclusion criteria

Exclusion criteria: Allergic to soy and egg yolk; hypertension;serious cardiovascular and cerebrovascular diseases; respiratory diseases such as asthma, COPD, snoring, and difficult airway; mental illness, recent use of mental drugs, pregnant and nursing women.

Design outcomes

Primary

MeasureTime frame
recovery time;BIS;—

Secondary

MeasureTime frame
Cycle fluctuations;—

Countries

China

Contacts

Public ContactYanning Qian

Jiangsu Province Hospital

yanning_qian@163.com+86 13951701214

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026